Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 24842 | 2017 |
Optimal medical therapy with or without PCI for stable coronary disease WE Boden, RA O'Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... New England journal of medicine 356 (15), 1503-1516, 2007 | 5580 | 2007 |
Optimal medical therapy with or without PCI for stable coronary disease WE Boden, RA O'Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... New England journal of medicine 356 (15), 1503-1516, 2007 | 5580 | 2007 |
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and … LJ Shaw, DS Berman, DJ Maron, GBJ Mancini, SW Hayes, PM Hartigan, ... Circulation 117 (10), 1283-1291, 2008 | 1950 | 2008 |
Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI … WE Boden, RA O’rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... N Engl J Med 356 (15), 1503-16, 2007 | 555 | 2007 |
Effect of PCI on long-term survival in patients with stable ischemic heart disease SP Sedlis, PM Hartigan, KK Teo, DJ Maron, JA Spertus, GBJ Mancini, ... New England Journal of Medicine 373 (20), 1937-1946, 2015 | 353 | 2015 |
Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without pci for stable coronary disease WE Boden, RA O’Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... N Engl J Med 356 (15), 1503-1516, 2007 | 330 | 2007 |
Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia GBJ Mancini, PM Hartigan, LJ Shaw, DS Berman, SW Hayes, ER Bates, ... JACC: Cardiovascular Interventions 7 (2), 195-201, 2014 | 221 | 2014 |
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without … LJ Shaw, WS Weintraub, DJ Maron, PM Hartigan, R Hachamovitch, ... American heart journal 164 (2), 243-250, 2012 | 195 | 2012 |
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients WS Weintraub, WE Boden, Z Zhang, P Kolm, Z Zhang, JA Spertus, ... Circulation: Cardiovascular Quality and Outcomes 1 (1), 12-20, 2008 | 169* | 2008 |
Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease SP Sedlis, CT Jurkovitz, PM Hartigan, DS Goldfarb, JD Lorin, M Dada, ... The American journal of cardiology 104 (12), 1647-1653, 2009 | 129 | 2009 |
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs cooperative studies program no. 424 WE Boden, RA O'rourke, KK Teo, PM Hartigan, DJ Maron, W Kostuk, ... American Heart Journal 151 (6), 1173-1179, 2006 | 121* | 2006 |
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive … DJ Maron, WE Boden, RA O'Rourke, PM Hartigan, KJ Calfas, ... Journal of the American College of Cardiology 55 (13), 1348-1358, 2010 | 117 | 2010 |
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE … S Acharjee, WE Boden, PM Hartigan, KK Teo, DJ Maron, SP Sedlis, ... Journal of the American College of Cardiology 62 (20), 1826-1833, 2013 | 116 | 2013 |
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and … WE Boden, RA O’Rourke, KK Teo, PM Hartigan, DJ Maron, W Kostuk, ... The American journal of cardiology 99 (2), 208-212, 2007 | 113* | 2007 |
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease … WE Boden, RA O'Rourke, KK Teo, DJ Maron, PM Hartigan, SP Sedlis, ... The American journal of cardiology 104 (1), 1-4, 2009 | 103 | 2009 |
COURAGE Investigators Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing … LJ Shaw, DS Berman, DJ Maron, GB Mancini, SW Hayes, PM Hartigan, ... Circulation 117 (10), 1283-1291, 2008 | 76 | 2008 |
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE … KK Teo, SP Sedlis, WE Boden, RA O'Rourke, DJ Maron, PM Hartigan, ... Journal of the American College of Cardiology 54 (14), 1303-1308, 2009 | 66 | 2009 |
Influence of chronic exercise on carotid atherosclerosis in marathon runners BA Taylor, AL Zaleski, JA Capizzi, KD Ballard, C Troyanos, AL Baggish, ... BMJ open 4 (2), e004498, 2014 | 61 | 2014 |
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization … DJ Maron, WE Boden, JA Spertus, PM Hartigan, GBJ Mancini, SP Sedlis, ... Journal of the American College of Cardiology 58 (2), 131-137, 2011 | 61 | 2011 |